CASI Pharmaceuticals
CASI
#9504
Rank
โ‚ฌ39.25 M
Marketcap
2,54ย โ‚ฌ
Share price
-5.02%
Change (1 day)
-56.19%
Change (1 year)

Revenue for CASI Pharmaceuticals (CASI)

Revenue in 2024 (TTM): โ‚ฌ20.06 Million

According to CASI Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ21.13 Million. In 2023 the company made a revenue of โ‚ฌ30.64 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ40.18 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CASI Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ20.06 M-34.53%
2023 โ‚ฌ30.64 M-23.74%
2022 โ‚ฌ40.18 M50.86%
2021 โ‚ฌ26.63 M116.4%
2020 โ‚ฌ12.3 M233.81%
2019 โ‚ฌ3.68 M
2018 N/A
2017 N/A
2016 N/A-100%
2015 โ‚ฌ0.04 M123.67%
2014 โ‚ฌ0.01 M
2013 N/A-100%
2012 โ‚ฌ0.5 M-66.14%
2011 โ‚ฌ1.49 M-46.17%
2010 โ‚ฌ2.77 M-24.72%
2009 โ‚ฌ3.68 M
2005 โ‚ฌ4.99 M1218.46%
2004 โ‚ฌ0.37 M-69.72%
2003 โ‚ฌ1.25 M11.19%
2002 โ‚ฌ1.12 M-46.62%
2001 โ‚ฌ2.1 M-45.91%
2000 โ‚ฌ3.89 M-21.13%
1999 โ‚ฌ4.94 M12.78%
1998 โ‚ฌ4.38 M8.33%
1997 โ‚ฌ4.04 M9.09%
1996 โ‚ฌ3.7 M